|
|
Volumn 9, Issue 6, 2008, Pages 505-508
|
|
Bitter medicine. New regulations aim to address the dearth of clinical safety trials for drugs used in children
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHLORAMPHENICOL;
PROPOFOL;
ARTICLE;
CHILD HEALTH CARE;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG FATALITY;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG MEGADOSE;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
EVIDENCE BASED MEDICINE;
HEART DISEASE;
HEART FAILURE;
HUMAN;
HYPOTHERMIA;
INFORMED CONSENT;
ISCHEMIA;
METABOLIC ACIDOSIS;
MORALITY;
NEWBORN DISEASE;
PATENT;
PHARMACEUTICAL CARE;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
PROTECTION;
RESEARCH ETHICS;
RISK BENEFIT ANALYSIS;
SEDATION;
VOMITING;
ADOLESCENT;
ADULT;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS AS TOPIC;
FEMALE;
HUMANS;
INFANT;
INFANT, NEWBORN;
PEDIATRICS;
PHARMACEUTICAL PREPARATIONS;
PREGNANCY;
SAFETY;
SOCIAL CONTROL, FORMAL;
|
|
EID: 44649098787
PISSN: 1469221X
EISSN: 14693178
Source Type: Journal
DOI: 10.1038/embor.2008.95 Document Type: Article |
|
Times cited : (7)
|
|
References (9)
|
